ZEB2 and acute myeloid leukemia: Although ZEB2 is best known for its role in repressing E-cadherin and promoting epithelial–mesenchymal transition (EMT), recent studies have associated its aberrant expression in AML and ETP-ALL with gross maturational arrest and an aggressive poorly differentiated stem-cell-like leukemia [6, 7].